Limitations of Vancomycin in the Management of Resistant Staphylococcal Infections
Open Access
- 15 September 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (Supplement), S191-S195
- https://doi.org/10.1086/519470
Abstract
Vancomycin is effective against methicillin-resistant Staphylococcus aureus and has been widely used in the past few years. However, several recent rKeywords
This publication has 26 references indexed in Scilit:
- Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2007
- Impact of Antibiotics on Expression of Virulence‐Associated Exotoxin Genes in Methicillin‐Sensitive and Methicillin‐ResistantStaphylococcus aureusThe Journal of Infectious Diseases, 2007
- Vancomycin: A HistoryClinical Infectious Diseases, 2006
- The Role of Vancomycin in the Treatment ParadigmClinical Infectious Diseases, 2006
- Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus PneumoniaChest, 2005
- Decreasing in Vitro Susceptibility of Clinical Staphylococcus aureus Isolates to Vancomycin at the New York Hospital: Quantitative Testing ReduxClinical Infectious Diseases, 2005
- Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin TherapyClinical Infectious Diseases, 2004
- Staphylococcus aureus BacteremiaMedicine, 2003
- Bacteremic Pneumonia Due to Staphylococcus aureus: A Comparison of Disease Caused by Methicillin-Resistant and Methicillin-Susceptible OrganismsClinical Infectious Diseases, 1999
- Vancomycin for Staphylococcus aureus endocarditis in intravenous drug usersAntimicrobial Agents and Chemotherapy, 1990